Previous studies have demonstrated that HDAC9 is associated with the pathogenesis of cardiometabolic diseases such as atherosclerosis [13,14,15,16,17] and diabetes [7], and that global HDAC9 KO mice are protected against obesity-related metabolic disease. This evidence concerns the gene HDAC9 and diabetes mellitus.